history of glp 1 agonists The transformative breakthroughs in GLP-1 research recognized by the 2024 Lasker~DeBakey award | Current Medicine GLP-1 Receptor Agonist Market Size

S.NielsenR.HnselmannA.et al (2017)

Ask the doctor Harvard Health Letter

Researchers have yet to establish a clear causal link between GLP-1 medications and these vision complications

Camilleri recently reviewed multiple studies that assessed lung aspiration in endoscopic procedures and found the risk to be low, with studies showing rates that were similar to patients not taking GLP-1 drugs: 4.8 versus 4.6 cases per 10,000 patients, respectively (4)

Metabolic effects of glucagon in the Wistar Rat

GLP-1 drugs, formally called glucagon-like peptide-1 receptor agonists, are incretin-based therapies that activate the GLP-1 receptor